FDA
approval
· 2017-08-02
FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Original Application (Nexus Pharmaceuticals LLC)
Summary
FDA approved Nexus Pharmaceuticals LLC's original-application submission for isoproterenol hydrochloride, making this generic beta-adrenergic agonist available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ISOPROTERENOL HYDROCHLORIDE (ISOPROTERENOL HYDROCHLORIDE)